Literature DB >> 31749096

The Short-Term Outcomes of Gastric Cancer Patients Based on a Proposal for a Novel Classification of Perigastric Arteries.

Shuai Shen1, Shougen Cao1, Haitao Jiang1, Shanglong Liu1, Xiaodong Liu1, Zequn Li1, Dan Liu1, Yanbing Zhou2.   

Abstract

PURPOSE: To establish a novel classification of perigastric arteries by computerized tomography angiography (CTA) and discuss its influence in patients' short-term clinical outcomes.
METHODS: The clinical data were analyzed retrospectively from 680 gastric cancer patients. The types of the perigastric artery were classified according to CTA image and we compared the short-term clinical outcomes.
RESULTS: The perigastric arteries can be divided into seven categories. Type I, trifurcation of the celiac trunk (CT) (294/343, 85.7%); type II, hepatosplenic trunk, left gastric artery (LGA) arising from the abdominal aorta (8/343, 2.3%); type III, hepatogastric trunk, splenic artery arising from the superior mesenteric artery (SMA) (2/343, 0.6%); type IV, celiacomesenteric trunk (5/343, 1.5%); type V, common hepatic artery (CHA) arising from the SMA, gastrosplenic trunk (11/343, 3.2%); type VI, aberrant (accessory or replaced) left hepatic artery arising from LGA (21/343, 6.1%); and type VII, CHA arising from LGA (2/343, 0.6%). The number of retrieved LNs in the CTA group was significantly higher than that in the non-CTA group. However, the operation time, estimated blood loss, intraoperative vascular injury, and medical cost of the CTA group were significantly less than those in the non-CTA group. Of note, in patients with BMI ≥ 25.0, higher LNs retrieval and less vascular injury were still present in the CTA group, which was of vital importance in clinical practice. Furthermore, the CTA group displayed shorter hospital stay (LOS).
CONCLUSION: We established a new perigastric artery classification. Application of the classification can improve the short-term clinical outcomes of patients.

Entities:  

Keywords:  CTA; Clinical outcome; Gastrectomy; Vascular variation

Mesh:

Year:  2019        PMID: 31749096     DOI: 10.1007/s11605-019-04427-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  4 in total

1.  Study on the application of preoperative three-dimensional CT angiography of perigastric arteries in laparoscopic radical gastrectomy.

Authors:  Peng Liu; Meng Wei; Danping Sun; Xin Zhong; Yize Liang; Jun Ouyang; Yuan Zhang; Wenbin Yu
Journal:  Sci Rep       Date:  2022-04-11       Impact factor: 4.379

2.  Effects of perioperative enhanced recovery after surgery pathway management versus traditional management on the clinical outcomes of laparoscopic-assisted radical resection of distal gastric cancer: study protocol for a randomized controlled trial.

Authors:  Yulong Tian; Shougen Cao; Leping Li; Qingsi He; Lijian Xia; Lixin Jiang; Yinlu Ding; Xinjian Wang; Hao Wang; Weizheng Mao; Xizeng Hui; Yiran Shi; Huanhu Zhang; Xianqun Chu; Henrik Kehlet; Yanbing Zhou
Journal:  Trials       Date:  2020-05-01       Impact factor: 2.279

3.  Effect of preoperative CT angiography examination on the clinical outcome of patients with BMI ≥ 25.0 kg/m2 undergoing laparoscopic gastrectomy: study protocol for a multicentre randomized controlled trial.

Authors:  Cheng Meng; Shougen Cao; Xiaodong Liu; Leping Li; Qingsi He; Lijian Xia; Lixin Jiang; Xianqun Chu; Xinjian Wang; Hao Wang; Xizeng Hui; Zuocheng Sun; Shusheng Huang; Quanhong Duan; Daogui Yang; Huanhu Zhang; Yulong Tian; Zequn Li; Yanbing Zhou
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.728

4.  Randomized Controlled Trial Comparing the Short-term Outcomes of Enhanced Recovery After Surgery and Conventional Care in Laparoscopic Distal Gastrectomy (GISSG1901).

Authors:  Yulong Tian; Shougen Cao; Xiaodong Liu; Leping Li; Qingsi He; Lixin Jiang; Xinjian Wang; Xianqun Chu; Hao Wang; Lijian Xia; Yinlu Ding; Weizheng Mao; Xizeng Hui; Yiran Shi; Huanhu Zhang; Zhaojian Niu; Zequn Li; Haitao Jiang; Henrik Kehlet; Yanbing Zhou
Journal:  Ann Surg       Date:  2022-01-01       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.